Alzheimer's Drug Is Up for Accelerated Approval. Outlook for Biogen, Eisai Is Uncertain.Barrons • 07/06/22
Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital PlatformBusiness Wire • 06/22/22
European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)GlobeNewsWire • 06/21/22
Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase AgreementBenzinga • 06/15/22
New Data Presented at Cure SMA Reveal Residual Unmet Needs in Young SMA Patients Treated With Gene Therapy and Suggest Further Potential of Using SPINRAZA® (nusinersen)GlobeNewsWire • 06/15/22
The Biogen Foundation and Community Lab Celebrates 20 Years of Serving our CommunitiesGlobeNewsWire • 06/14/22
Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson's DiseaseGlobeNewsWire • 06/06/22